Drug intelligence / Profile preview

sodium phosphate, dibasic + sodium phosphate, monobasic

Development stage
Unknown
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous
01

Overview

Sodium Phosphates Injection is a sterile, concentrated intravenous solution containing a combination of sodium phosphate, dibasic, anhydrous and sodium phosphate, monobasic, monohydrate. Developed by Hospira (now a Pfizer company) and approved under NDA 018892, it functions as an inorganic electrolyte replenisher. The drug is primarily indicated for the prevention and treatment of hypophosphatemia in patients with restricted or no oral intake, as well as an additive for preparing specific parenteral fluid formulas. By restoring inorganic phosphate levels, it facilitates the synthesis of essential high-energy phosphates such as adenosine triphosphate (ATP) and 2,3-diphosphoglycerate (DPG), which are vital for cellular energy metabolism and erythrocyte function.

Brand names
Sodium Phosphates
Other names
Sodium Phosphates Injection, USP
02

Targets

Intestinal luminal osmolarity

Beyond the preview

Go deeper on sodium phosphate, dibasic + sodium phosphate, monobasic.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on sodium phosphate, dibasic + sodium phosphate, monobasic.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call